Kazuhiro Kakimi MD, PhD has been a leader in developing effective immunotherapies against cancer for the last 15 years in Japan. In this whitepaper, he and his colleagues have reported that the QuickSwitch™ Custom Tetramers will become an essential tool
Evaluating the biological activity of a cancer vaccine with the HLA-A*02:01 QuickSwitch™ Quant platform
Principle of the cell-based T2 shift assay and the cell-free QuickSwitch™ Quant assay Comparison of the cell-based T2 shift assay and the cell-free QuickSwitch™ Quant assay Immuno-oncology is a growing field in which different strategies such as immune modulators, vaccines
High-Quality Stock and Custom Peptides
Suitable for Stimulation Assays High-Quality Control ≥95% Purity and Mass Spec Analysed Custom tetramer generation using QuickSwitch™ and QuickSwitch™ Quant Tetramer MBL International‘s stock and custom peptides can be used for stimulation assays along with custom tetramer generation using
QuickSwitch™ – Quickly Create Custom Tetramers
Fast, High-Quality Generation of New Tetramer Specificities Rapid, high-quality creation of custom class I tetramers is now a reality! Create new specificity tetramers in just a few hours with QuickSwitch™ from MBL International; a proprietary technology for exchanging peptides on